Dompe NAION

Recruiting
50 years - 80 years
All
Phase 3
3 participants needed
1 Location

Brief description of study

This is a Phase 3 study to evaluate the efficacy and safety of intranasal cengermin compared with vehicle control in adult participants recently diagnosed with or suspected Non-Arteritic Ischemic Optic Neuropathy (NAION)

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Medical Research
  • Age: 50 years - 80 years
  • Gender: All

  • Confirmed clinical diagnosis of NAION with symptom onset within the past 14 days
  • Cannot have prior or planned use of systemic corticosteroids within the past 1 month
  • Cannot have prior or planned use of intranasal drugs for more than 7 cumulative days within the past month

Updated on 16 Jul 2026. Study ID: 26-6728

Pre-Screener

Check if you are eligible Enter contact details Select a study center Select best time to contact

When did you first experience symptoms of NAION?

Preview complete

The prescreener preview is complete. You may now close the preview.

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center